
According to Igea Hub, the global cancer therapeutics market in 2017 was worth $121bn and it is predicted to reach $176bn in 2022. Blockbuster drugs are crucial to oncology’s continuing dominance of the pharma market; Igea Hub identifies Celgene’s Revlimid as the leading product, but others include Merck’s Keytruda and Bristol Myers-Squibb’s Opdivo.
As oncology is such a crucial segment of the industry, GlobalData analysts have identified the top ten influential people in the oncology who have been engaging in interesting conversations on the topic this year.
1) Mike Thompson
A clinician by trade, Mike Thompson is currently the medical director of Aurora Healthcare’s early Phase Cancer Research Programme and Oncology Precision Medicine Programme. His work mainly focuses on blood cancers and conducting bio-market driven early stage clinical trials.
As well as being a member of various US medical societies, Thompson currently sits on the National Cancer Institute (NCI)’s lymphoma steering committee.
Twitter handle: @mtmdphd
Number of twitter followers: 18,386
Congratulations to our @Aurora_Cancer Oncology #PrecisionMedicine team (represented by Jenn & Brenda) for coordinating 1000 molecular panel tests since centralized ordering implementation Nov, 2017. Cc @mullane_michael @antonyruggeri pic.twitter.com/1KmaLPkBde
— Mike Thompson, MD, PhD, FASCO (@mtmdphd) June 28, 2019
2) Minas Chrysopoulo
Minas Chrysopoulo is the president of PRMA Plastic Surgery, which specialises in breast reconstructive surgery. He has used his extensive experience as a plastic surgeon to create the Breast Advocate App, a free platform to provide advice to breast cancer patients and survivors throughout the surgery decision process.
His work has been recognised by professional organisations, including being named as one of America’s top surgeons and winning the plastic surgery award at more than one Doctor’s Choice Awards.
Twitter handle: @drchrysopoulo
Number of twitter followers: 44,126
#ERAS (Enhanced Recovery After Surgery) -> Less pain, shorter hospital stay, faster recovery, and improved patient satisfaction and outcomes. #BreastReconstruction #BreastCancer #PlasticSurgery @diepflapbreast @BreastAdvocate https://t.co/2WX8RlGa9H
— Dr Minas Chrysopoulo (@drchrysopoulo) June 30, 2019
3) Kathleen Hoffman
Healthcare researcher and writer Kathleen Hoffman helps companies to better communicate complex medical information to and connect with patients on their websites and social media platforms. She also helps pharma clients to foster patient communities, partly through encouraging them to share their experiences through patient testimonials.
She holds a PhD in Communications from the University of Alabama and a post-doctorate in Health Communication from Harvard University.
Twitter handle: @drkdhoffman
Number of twitter followers: 15,838
Cherry Hughes says “No one wants to explain the damage that all the treatments do. There seems to be a conspiracy of silence amongst the medical profession…" .To treat or not to treat: Medical decision-making & cancer https://t.co/f0G0OPkUtc pic.twitter.com/U0Et56Wgbd
— Kathleen D. Hoffman (@drkdhoffman) July 1, 2019
4) Robert Orlowski
Robert Orlowski has been the director of University of Texas MD Anderson Cancer Centre’s myeloma department since 2007. He is also the Myeloma Committee Chair for the National Cancer Institute’s clinical trial segment SWOG.
His clinical research interests include understanding the mechanisms of drug resistance in myeloma, on which he has contributed to hundreds of articles, book chapters and conference presentations.
Twitter handle: @Myeloma_Doc
Number of twitter followers: 9,873
With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study https://t.co/lm3vDgztFW #myeloma
— Robert Z. Orlowski (@Myeloma_Doc) July 1, 2019
5) Matthew Katz
Originally studying history, before turning to medicine, Matthew Katz is a radiation oncologist at Lowell General Hospital in Massachusetts.
In addition to his work treating patients, Katz has founded two blogs, Subatomic doc and Rad Nation, where he shares his own peer-reviewed work and other people’s insights into improving cancer prevention and treatment.
Twitter handle: @subatomicdoc
Number of twitter followers: 17,725
Organizing Online Health Content: Developing Hashtag Collections for Healthier Internet-Based People and Communities https://t.co/maO5hw1HJF
Updated cancer tag ontology data and guidance in JCO CCI #bcsm #btsm #gyncsm #lcsm #mmsm #pancsm #ayacsm pic.twitter.com/nA5ICey25j
— Matthew Katz, MD 🇺🇸 (@subatomicdoc) June 28, 2019
6) Eric Topol
Cardiologist Eric Topol founded the Scripps Research Translational Institute in 2007; he remains its director to this day. This institute joined Scripps Research in 2017, at which point Topol became executive vice-president of the whole company.
His research focus combines genomics, big data and emerging technologies to achieve personalised medicine in oncology and other fields; he has been cited more than 200,000 times on these topics. Topol has recently published a book titled Deep Medicine, looking at the power of artificial intelligence to allow doctors to focus on listening to patients, rather than dealing with administrative tasks.
Twitter handle: @EricTopol
Number of twitter followers: 166,394
"Peto's Paradox": why do the largest animals, with the most cells to mutate, have the lowest incidence of #cancer?
what we are learning from whales and elephants https://t.co/ghH9wlJIiN @TheEconomist— Eric Topol (@EricTopol) June 28, 2019
7) Lisa Guzzardi
Lisa Guzzardi is a patient advocate who runs a journal club on Facebook, called the BRCA Advanced 101 & 102 Journal Club. The group comprises of academics and clinicians from across the world who share information on studies and articles of relevance to hereditary cancer patients.
Twitter handle: @LguzzardiM
Number of twitter followers: 6,738
@MassGeneralNews Expert discusses Phase III #Clinicaltrial Showing Benefit With #Olaparib in Platinum-Sensitive #BRCA + Relapsed #OvarianCancer#gyncsm #WomensHealth #cancerresearch #PARP #hereditarycancer
Via @TargetedOnc https://t.co/pBfZWFayTl
— Lisa M Guzzardi, RN (@LguzzardiM) June 30, 2019
8) Barbara Jacoby
Two-time breast cancer survivor Barbara Jacoby is a patient advocate and ambassador who shares her experiences and insight on her own blog Let Life Happen and other media outlets. Her blog has won multiple awards, including being named as Healthline.com’s top breast cancer blog seven years in a row.
On top of her blogging and day job at The Walt Disney Company, Jacoby serves on a number of advisory boards and committees, such as Novartis, DiepC Foundation and the Breast Advocate App, founded by Chrysopoulo.
Twitter handle: @letlifehappen
Number of twitter followers: 23,014
6 months treatment with Herceptin is as good as 12 months for preventing breast cancer return https://t.co/MCujw27lwS
— Barbara Jacoby (@letlifehappen) June 30, 2019
9) Elizabeth O’Riordan
Former breast surgeon Elizabeth O’Riordan was diagnosed with Stage three breast cancer in 2015 and to deal with her predicament she started a cancer blog to track her journey through treatment.
Linked to this, O’Riordan has co-authored a book with Professor Trisha Greenhalgh called ‘The Complete Guide to Breast Cancer with the aim of empowering patients through treatments. She has also given Tedx and key-note speeches about collecting moments of joy while fighting cancer.
Twitter handle: @Liz_ORiordan
Number of twitter followers: 18,287
Dear @BNFormulary – many female cancer patients suffer severe vaginal atrophy because of cancer treatment and are entitled to free prescriptions. Why can't vaginal moisturisers/lubricants be added? @guardian @HuffPostUK @BarneyCalman @BBCWomansHour @Theyescompany @eveappeal https://t.co/ji4S8CMKe9
— Dr Liz O'Riordan (@Liz_ORiordan) June 25, 2019
10) Christina Lizaso
Christina Lizaso is the co-founder of Gyncsm, an online community for people impacted by gynaecologic cancers, including patients, survivors, families or carers of patients and those at high risk of developing these cancers. One of her co-founders is ovarian cancer survivor Dee Sparacio, who ranks 14th on GlobalData’s oncology influencer platform.
Lizaso also blogs for Cure Media, is a digital ambassador at the National Society of Genetic Counselors and is a patient advisor on the board of Clara Health.
Twitter Handle: @btrfly12
Number of twitter followers: 5,823
Link: https://t.co/8eM1z10UxH https://t.co/9416BMVmPr
— Christina Lizaso (@btrfly12) June 27, 2019
Methodology
The analysis provided by GlobalData is based on the number of company or organisation mentions, online engagement by influencers, and expert analysis.
A more detailed daily analysis is available for GlobalData subscribers.